Literature DB >> 21324901

Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin.

Wing S To1, Kim S Midwood.   

Abstract

Interactions between fibronectin and tenascin-C within the extracellular matrix provide specific environmental cues that dictate tissue structure and cell function. The major binding site for fibronectin lies within the fibronectin type III-like repeats (TNfn) of tenascin-C. Here, we systematically screened TNfn domains for their ability to bind to both soluble and fibrillar fibronectin. All TNfn domains containing the TNfn3 module interact with soluble fibronectin. However, TNfn domains bind differentially to fibrillar fibronectin. This distinct binding pattern is dictated by the fibrillar conformation of FN. TNfn1-3, but not TNfn3-5, binds to immature fibronectin fibrils, and additional TNfn domains are required for binding to mature fibrils. Multiple binding sites for distinct regions of fibronectin exist within tenascin-C. TNfn domains comprise a binding site for the N-terminal 70-kDa domain of fibronectin that is freely available and a binding site for the central binding domain of fibronectin that is cryptic in full-length tenascin-C. The 70-kDa and central binding domain regions are key for fibronectin matrix assembly; accordingly, binding of several TNfn domains to these regions inhibits fibronectin fibrillogenesis. These data highlight the complexity of protein-protein binding, the importance of protein conformation on these interactions, and the implications for the physiological assembly of complex three-dimensional matrices.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324901      PMCID: PMC3083171          DOI: 10.1074/jbc.M110.189019

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Fibronectin: structure, assembly, and cardiovascular implications.

Authors:  M K Magnusson; D F Mosher
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-09       Impact factor: 8.311

2.  Module-module interactions in the cell binding region of fibronectin: stability, flexibility and specificity.

Authors:  C Spitzfaden; R P Grant; H J Mardon; I D Campbell
Journal:  J Mol Biol       Date:  1997-02-07       Impact factor: 5.469

3.  Tenascin expression during wound healing in human skin.

Authors:  M A Latijnhouwers; M Bergers; B H Van Bergen; K I Spruijt; M P Andriessen; J Schalkwijk
Journal:  J Pathol       Date:  1996-01       Impact factor: 7.996

4.  Tenascin-C matrix assembly in oral squamous cell carcinoma.

Authors:  D M Ramos; B Chen; J Regezi; L Zardi; R Pytela
Journal:  Int J Cancer       Date:  1998-03-02       Impact factor: 7.396

5.  Cryptic self-association sites in type III modules of fibronectin.

Authors:  K C Ingham; S A Brew; S Huff; S V Litvinovich
Journal:  J Biol Chem       Date:  1997-01-17       Impact factor: 5.157

6.  Heparin binding by fibronectin module III-13 involves six discontinuous basic residues brought together to form a cationic cradle.

Authors:  T F Busby; W S Argraves; S A Brew; I Pechik; G L Gilliland; K C Ingham
Journal:  J Biol Chem       Date:  1995-08-04       Impact factor: 5.157

7.  Binding of tenascin-C to soluble fibronectin and matrix fibrils.

Authors:  C Y Chung; L Zardi; H P Erickson
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

8.  Glycosaminoglycans modulate fibronectin matrix assembly and are essential for matrix incorporation of tenascin-C.

Authors:  C Y Chung; H P Erickson
Journal:  J Cell Sci       Date:  1997-06       Impact factor: 5.285

9.  Altered rate of fibronectin matrix assembly by deletion of the first type III repeats.

Authors:  J L Sechler; Y Takada; J E Schwarzbauer
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

10.  A novel role for the integrin-binding III-10 module in fibronectin matrix assembly.

Authors:  D C Hocking; R K Smith; P J McKeown-Longo
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  9 in total

Review 1.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

2.  Wounded embryonic corneas exhibit nonfibrotic regeneration and complete innervation.

Authors:  James W Spurlin; Peter Y Lwigale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-24       Impact factor: 4.799

3.  Expression of scleraxis and tenascin C in equine adipose and umbilical cord blood derived stem cells is dependent upon substrata and FGF supplementation.

Authors:  Sarah A Reed; Sally E Johnson
Journal:  Cytotechnology       Date:  2013-01-09       Impact factor: 2.058

Review 4.  Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.

Authors:  Josephine M J Stoffels; Chao Zhao; Wia Baron
Journal:  Cell Mol Life Sci       Date:  2013-06-12       Impact factor: 9.261

5.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16

Review 6.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

7.  The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer.

Authors:  Yingqiang Xu; Zhonghu Li; Peng Jiang; Guo Wu; Kai Chen; Xi Zhang; Xiaowu Li
Journal:  Diagn Pathol       Date:  2015-12-10       Impact factor: 2.644

8.  Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells.

Authors:  Maria E Vega; John B Finlay; Mansi Vasishtha; Jean E Schwarzbauer
Journal:  Matrix Biol Plus       Date:  2020-09-30

Review 9.  Matricellular protein tenascin C: Implications in glioma progression, gliomagenesis, and treatment.

Authors:  Zaixiang Fu; Ganggui Zhu; Chao Luo; Zihang Chen; Zhangqi Dou; Yike Chen; Chen Zhong; Sheng Su; Fuyi Liu
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.